308 related articles for article (PubMed ID: 32386596)
1. Targeted Degradation of SLC Transporters Reveals Amenability of Multi-Pass Transmembrane Proteins to Ligand-Induced Proteolysis.
Bensimon A; Pizzagalli MD; Kartnig F; Dvorak V; Essletzbichler P; Winter GE; Superti-Furga G
Cell Chem Biol; 2020 Jun; 27(6):728-739.e9. PubMed ID: 32386596
[TBL] [Abstract][Full Text] [Related]
2. Covalent Ligand Screening Uncovers a RNF4 E3 Ligase Recruiter for Targeted Protein Degradation Applications.
Ward CC; Kleinman JI; Brittain SM; Lee PS; Chung CYS; Kim K; Petri Y; Thomas JR; Tallarico JA; McKenna JM; Schirle M; Nomura DK
ACS Chem Biol; 2019 Nov; 14(11):2430-2440. PubMed ID: 31059647
[TBL] [Abstract][Full Text] [Related]
3. Establishment of a novel microscale thermophoresis ligand-binding assay for characterization of SLC solute carriers using oligopeptide transporter PepT1 (SLC15 family) as a model system.
Clémençon B; Lüscher BP; Hediger MA
J Pharmacol Toxicol Methods; 2018; 92():67-76. PubMed ID: 29580877
[TBL] [Abstract][Full Text] [Related]
4. Molecular modeling and ligand docking for solute carrier (SLC) transporters.
Schlessinger A; Khuri N; Giacomini KM; Sali A
Curr Top Med Chem; 2013; 13(7):843-56. PubMed ID: 23578028
[TBL] [Abstract][Full Text] [Related]
5. Ligand-induced genetic degradation as a tool for target validation.
Yesbolatova A; Tominari Y; Kanemaki MT
Drug Discov Today Technol; 2019 Apr; 31():91-98. PubMed ID: 31200864
[TBL] [Abstract][Full Text] [Related]
6. Proteolysis-targeting chimera (PROTAC) for targeted protein degradation and cancer therapy.
Li X; Song Y
J Hematol Oncol; 2020 May; 13(1):50. PubMed ID: 32404196
[TBL] [Abstract][Full Text] [Related]
7. Rational exploration of fold atlas for human solute carrier proteins.
Xie T; Chi X; Huang B; Ye F; Zhou Q; Huang J
Structure; 2022 Sep; 30(9):1321-1330.e5. PubMed ID: 35700727
[TBL] [Abstract][Full Text] [Related]
8. Transporter-Mediated Drug Delivery.
Gyimesi G; Hediger MA
Molecules; 2023 Jan; 28(3):. PubMed ID: 36770817
[TBL] [Abstract][Full Text] [Related]
9. Induced protein degradation of anaplastic lymphoma kinase (ALK) by proteolysis targeting chimera (PROTAC).
Kang CH; Lee DH; Lee CO; Du Ha J; Park CH; Hwang JY
Biochem Biophys Res Commun; 2018 Oct; 505(2):542-547. PubMed ID: 30274779
[TBL] [Abstract][Full Text] [Related]
10. Targeting SLC transporters: small molecules as modulators and therapeutic opportunities.
Schlessinger A; Zatorski N; Hutchinson K; Colas C
Trends Biochem Sci; 2023 Sep; 48(9):801-814. PubMed ID: 37355450
[TBL] [Abstract][Full Text] [Related]
11. A substrate-based ontology for human solute carriers.
Meixner E; Goldmann U; Sedlyarov V; Scorzoni S; Rebsamen M; Girardi E; Superti-Furga G
Mol Syst Biol; 2020 Jul; 16(7):e9652. PubMed ID: 32697042
[TBL] [Abstract][Full Text] [Related]
12. Structural prediction of two novel human atypical SLC transporters, MFSD4A and MFSD9, and their neuroanatomical distribution in mice.
Perland E; Hellsten SV; Schweizer N; Arapi V; Rezayee F; Bushra M; Fredriksson R
PLoS One; 2017; 12(10):e0186325. PubMed ID: 29049335
[TBL] [Abstract][Full Text] [Related]
13. The solute carrier (SLC) complement of the human genome: phylogenetic classification reveals four major families.
Fredriksson R; Nordström KJ; Stephansson O; Hägglund MG; Schiöth HB
FEBS Lett; 2008 Nov; 582(27):3811-6. PubMed ID: 18948099
[TBL] [Abstract][Full Text] [Related]
14. The ABCs of membrane transporters in health and disease (SLC series): introduction.
Hediger MA; Clémençon B; Burrier RE; Bruford EA
Mol Aspects Med; 2013; 34(2-3):95-107. PubMed ID: 23506860
[TBL] [Abstract][Full Text] [Related]
15. Structural biology of solute carrier (SLC) membrane transport proteins.
Bai X; Moraes TF; Reithmeier RAF
Mol Membr Biol; 2017; 34(1-2):1-32. PubMed ID: 29651895
[TBL] [Abstract][Full Text] [Related]
16. Modular PROTAC Design for the Degradation of Oncogenic BCR-ABL.
Lai AC; Toure M; Hellerschmied D; Salami J; Jaime-Figueroa S; Ko E; Hines J; Crews CM
Angew Chem Int Ed Engl; 2016 Jan; 55(2):807-10. PubMed ID: 26593377
[TBL] [Abstract][Full Text] [Related]
17. Emerging mechanisms of targeted protein degradation by molecular glues.
Frere GA; de Araujo ED; Gunning PT
Methods Cell Biol; 2022; 169():1-26. PubMed ID: 35623698
[TBL] [Abstract][Full Text] [Related]
18. The Novel Membrane-Bound Proteins MFSD1 and MFSD3 are Putative SLC Transporters Affected by Altered Nutrient Intake.
Perland E; Hellsten SV; Lekholm E; Eriksson MM; Arapi V; Fredriksson R
J Mol Neurosci; 2017 Feb; 61(2):199-214. PubMed ID: 27981419
[TBL] [Abstract][Full Text] [Related]
19. Bivalent Ligands for Protein Degradation in Drug Discovery.
Scheepstra M; Hekking KFW; van Hijfte L; Folmer RHA
Comput Struct Biotechnol J; 2019; 17():160-176. PubMed ID: 30788082
[TBL] [Abstract][Full Text] [Related]
20. New strategy for renal fibrosis: Targeting Smad3 proteins for ubiquitination and degradation.
Wang X; Feng S; Fan J; Li X; Wen Q; Luo N
Biochem Pharmacol; 2016 Sep; 116():200-9. PubMed ID: 27473774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
